CY2269B1 - Bioadhesive solid dosage form - Google Patents

Bioadhesive solid dosage form

Info

Publication number
CY2269B1
CY2269B1 CY0200020A CY0200020A CY2269B1 CY 2269 B1 CY2269 B1 CY 2269B1 CY 0200020 A CY0200020 A CY 0200020A CY 0200020 A CY0200020 A CY 0200020A CY 2269 B1 CY2269 B1 CY 2269B1
Authority
CY
Cyprus
Prior art keywords
solid dosage
dosage form
dosage forms
bioadhesive
bioadhesive solid
Prior art date
Application number
CY0200020A
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY2269B1 publication Critical patent/CY2269B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0200020A 1995-12-27 2002-04-25 Bioadhesive solid dosage form CY2269B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95203649 1995-12-27

Publications (1)

Publication Number Publication Date
CY2269B1 true CY2269B1 (en) 2003-07-04

Family

ID=8221021

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200020A CY2269B1 (en) 1995-12-27 2002-04-25 Bioadhesive solid dosage form

Country Status (27)

Country Link
US (1) US6303147B1 (fr)
EP (1) EP0869772B1 (fr)
JP (1) JP4317264B2 (fr)
KR (1) KR100459029B1 (fr)
CN (1) CN1146401C (fr)
AT (1) ATE206304T1 (fr)
AU (1) AU713849B2 (fr)
BR (1) BR9612291A (fr)
CA (1) CA2232152C (fr)
CY (1) CY2269B1 (fr)
CZ (1) CZ298690B6 (fr)
DE (1) DE69615704T2 (fr)
DK (1) DK0869772T3 (fr)
EA (1) EA000818B1 (fr)
ES (1) ES2164940T3 (fr)
HK (1) HK1015680A1 (fr)
HU (1) HU228350B1 (fr)
IL (1) IL123636A (fr)
NO (1) NO320015B1 (fr)
NZ (1) NZ325844A (fr)
PL (1) PL186278B1 (fr)
PT (1) PT869772E (fr)
SI (1) SI0869772T1 (fr)
SK (1) SK283370B6 (fr)
TR (1) TR199800894T2 (fr)
WO (1) WO1997024109A1 (fr)
ZA (1) ZA9610886B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
EP1117384A1 (fr) * 1998-10-01 2001-07-25 Elan Pharma International Limited Liberation regulee de compositions nanoparticulaires
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
CA2371940C (fr) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Amidon pregelatinise dans une formulation a liberation regulee
US7503493B2 (en) * 1999-10-25 2009-03-17 Silverbrook Research Pty Ltd Method and system for digitizing freehand graphics with user-selected properties
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US8980334B2 (en) 2001-02-28 2015-03-17 Axiomedic Ltd. Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
EP1236466B1 (fr) * 2001-02-28 2011-09-21 Axiomedic Ltd. Compositions auto-adhésives solides pour le traitement topique des troubles de la muqueuse orale
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20030083286A1 (en) * 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US7846478B2 (en) * 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
ATE464880T1 (de) 2002-02-04 2010-05-15 Elan Pharma Int Ltd Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
EP1667681A4 (fr) 2003-10-03 2009-09-30 Astron Res Pvt Ltd Nouveau systeme d'administration transmucosale
WO2005067887A2 (fr) * 2004-03-24 2005-07-28 Actavis Group Formulations de ramipril
WO2005102287A2 (fr) * 2004-04-22 2005-11-03 Duocort Ab Compositions pharmaceutiques pour therapie aux glucocorticoides aigue
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CA2576386A1 (fr) 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Preparation d'une pastille a autorisation de sortie elargie, contenant du pramipexole ou un sel de pramipexole pharmaceutiquement acceptable, procede de fabrication et d'utilisation de cette pastille
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US8349120B2 (en) * 2006-03-07 2013-01-08 Ora Health Corporation Multi-layer patch made on a sheet and enclosed in a blister
EP1837020A1 (fr) 2006-03-24 2007-09-26 Bioalliance Pharma Vehicule bioadhesif pour les muqueuses pour delivrer lentement des principes actifs
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
JP5410964B2 (ja) * 2006-05-23 2014-02-05 オラヘルス コーポレーション 付着性アカシアゴムを含む二層構造の口腔内付着錠
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CN101500583B (zh) * 2006-07-12 2012-05-23 控制治疗（苏格兰）有限公司 含克林霉素盐酸盐的药物递送聚合物
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
WO2009008006A2 (fr) * 2007-07-06 2009-01-15 Lupin Limited Compositions pharmaceutiques d'administration gastro-intestinale de médicaments
EP2942053A1 (fr) 2007-07-06 2015-11-11 Lupin Limited Compositions pharmaceutiques pour administration gastro-intestinale de médicaments
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP2163240A1 (fr) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova Méthode pour la production des matrices compactes bioadhésives
CA2822268A1 (fr) 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Perhydrolases ciblees
BR112015021097B1 (pt) * 2013-03-06 2022-08-30 Novartis Ag Composição farmacêutica sólida compactada em rolo, seu uso e seu processo de fabricação
CN105193768A (zh) * 2015-08-27 2015-12-30 武汉武药科技有限公司 一种曲安奈德口腔粘贴片及其制备工艺
PL3484486T3 (pl) * 2016-07-15 2023-12-11 H2 Water Technologies Ltd Kompozycja do produkcji wody bogatej w wodór

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554764A (en) * 1967-12-21 1971-01-12 Gen Foods Corp Freeze-thaw resistant flour and starch thickener blend
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
EP0451433B1 (fr) * 1990-04-12 1996-10-23 Janssen Pharmaceutica N.V. Composition d'un support bioadhésif pour la libération soutenue d'un principe actif
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5370878A (en) 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
TW355683B (en) 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5656283A (en) 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product

Also Published As

Publication number Publication date
PT869772E (pt) 2002-03-28
DE69615704T2 (de) 2002-07-11
HK1015680A1 (en) 1999-10-22
CA2232152A1 (fr) 1997-07-10
EP0869772A1 (fr) 1998-10-14
HUP9802913A2 (hu) 1999-06-28
IL123636A (en) 2001-04-30
HU228350B1 (hu) 2013-03-28
SK88798A3 (en) 1998-11-04
JP4317264B2 (ja) 2009-08-19
WO1997024109A1 (fr) 1997-07-10
EP0869772B1 (fr) 2001-10-04
EA199800350A1 (ru) 1998-10-29
SK283370B6 (sk) 2003-06-03
KR19990067112A (ko) 1999-08-16
TR199800894T2 (xx) 1998-08-21
CA2232152C (fr) 2007-02-06
NO981027D0 (no) 1998-03-09
PL326196A1 (en) 1998-08-31
ES2164940T3 (es) 2002-03-01
KR100459029B1 (ko) 2006-03-27
CZ298690B6 (cs) 2007-12-27
AU1308597A (en) 1997-07-28
ATE206304T1 (de) 2001-10-15
NO981027L (no) 1998-06-15
CN1200667A (zh) 1998-12-02
JP2000502691A (ja) 2000-03-07
PL186278B1 (pl) 2003-12-31
DK0869772T3 (da) 2002-01-21
ZA9610886B (en) 1998-06-23
NO320015B1 (no) 2005-10-10
IL123636A0 (en) 1998-10-30
CZ199298A3 (cs) 1998-09-16
CN1146401C (zh) 2004-04-21
DE69615704D1 (de) 2001-11-08
HUP9802913A3 (en) 2000-06-28
SI0869772T1 (en) 2002-04-30
EA000818B1 (ru) 2000-04-24
BR9612291A (pt) 1999-07-13
NZ325844A (en) 1999-06-29
AU713849B2 (en) 1999-12-09
US6303147B1 (en) 2001-10-16

Similar Documents

Publication Publication Date Title
PL326196A1 (en) Bioadhesive solid administration form
BG66114B1 (bg) Многофазов състав на дросперидон като контрацептив
BG105857A (en) Pregelatinized starch in a controlled release formulation
CA2159580A1 (fr) Compositions pharmaceutiques renfermant la polyvinylpyrrolidone et un tri-ester; methode de preparation
MY118371A (en) Tetrahydrolipstatin containing compositions
ES534096A0 (es) Procedimiento de obtencion de tabletas farmaceuticas administrables por via oral
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
CA2445519A1 (fr) Procede permettant de preparer une composition pharmaceutique faiblement dosee, a repartition et a activite uniformes du medicament
CA2214026A1 (fr) Compositions pharmaceutiques comprenant des inhibiteurs de la monoamine oxydase b
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
CA2330480A1 (fr) Preparation a liberation controlee de divalproex sodium
NZ510563A (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
HK1023508A1 (en) Stabilized tibolone compositions.
CA2318260A1 (fr) Compositions pharmaceutiques solides contenant miltefosine et servant a traiter la leishmaniose par administration orale
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
CA2348474A1 (fr) Composition d'une substance pharmaceutiquement active et dispositif de distribution
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
MX9802026A (es) Formulaciones farmaceuticas que contienen darifenacina.